Immediate Impact

57 standout
Sub-graph 1 of 21

Citing Papers

Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options
2025 Standout
Metabolic reprogramming in liver fibrosis
2024 Standout
2 intermediate papers

Works of Diego Lucero being referenced

Atherogenic Lipoproteins in Subclinical Hypothyroidism and Their Relationship with Hepatic Lipase Activity: Response to Replacement Treatment with Levothyroxine
2016
Pro-inflammatory and atherogenic circulating factors in non-alcoholic fatty liver disease associated to metabolic syndrome
2010

Author Peers

Author Last Decade Papers Cites
Diego Lucero 247 212 112 141 26 487
Bruno Vergès 252 203 60 163 14 449
C. Alagona 349 251 99 87 14 526
Nebojša Kavarić 152 204 122 124 39 568
A. Tselepis 132 191 95 162 22 523
Alexandros Sachinidis 222 122 112 110 17 566
Oğuzhan Öztürk 158 355 109 63 28 531
Celal Ulaşoğlu 147 295 103 107 31 502
P R Wenham 174 89 59 143 32 566
Yanzhen Cheng 152 161 66 147 21 556
Rose M. Fields 255 90 71 192 15 549

All Works

Loading papers...

Rankless by CCL
2026